Burkholderia cepacia Complex Vaccines: Where Do We Go from here? - Wikidata - wikimedia - TriplyDB

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

http://www.wikidata.org/entity/Q26752346

about

The art of persistence-the secrets to Burkholderia chronic infections.Characterization of the Burkholderia cenocepacia TonB Mutant as a Potential Live Attenuated Vaccine.Vaccines for the Prevention of Melioidosis and Glanders.

P2860

Q38839466-2A903785-982C-40DA-A59D-37A842D7EB26 Q47168921-C975ADC4-D256-4E58-8913-9105AAFC8740 Q49834322-0761C89C-E4D8-4ED2-8AF6-1835B373977F

P2860

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

http://www.wikidata.org/entity/Q26752346

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@ast

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@en

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@nl

type

label

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@ast

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@en

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@nl

prefLabel

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@ast

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@en

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@nl

P1433

Q26752346-3C168CCB-559A-4772-BD47-77770006CCEF

P1476

Q26752346-EB26162D-E9BA-48F1-975B-28B8F4327D25

P2093

Q26752346-2EF629BD-3915-4CEC-9B93-9C202C0686F1

P2860

Q26752346-013FEB61-4D02-4034-A1CF-07271B40906C

Q26752346-01F0C816-6C62-4362-862E-937853D526B1

Q26752346-04A2D116-0011-47A4-8F8C-8A24C358CE9D

Q26752346-0DF4CD5C-C40E-46B5-B0CF-2C707354F5AC

Q26752346-0E6D2A47-ABE9-43FC-97ED-A5FB4570D626

Q26752346-10987699-262D-4309-B0FE-FA98691DCF24

Q26752346-13896AA9-8A3B-425E-ACF2-FA2F6D90F6D1

Q26752346-1756A8A7-5036-4819-918A-3F3161A4CC86

Q26752346-188D500D-9179-45F6-8439-37EA497C03CF

Q26752346-1B7F53B5-28F6-4092-8732-E44D8DECF94A

P304

Q26752346-0409057A-9AC0-4323-B742-0A3311C9A8F1

P31

Q26752346-8BBD9856-2D70-4F60-B828-5DCD1B3E02E8

P3181

Q26752346-85B76108-FC79-4DB5-87EB-7C6936DAA729

P356

Q26752346-454A56D2-DC05-4968-A358-47A612D84AD7

P407

Q26752346-A5AC1340-FFC0-47F6-A910-8987CCDBB31F

P433

Q26752346-C04D113C-8DEF-49F9-B228-9ACCEDCC63BF

P478

Q26752346-B475B859-3DC2-49D1-A485-FAD977137EC5

P50

Q26752346-AA9DD1D3-3E46-42EE-988C-527E413949E1

Q26752346-DDADA5AE-7D7E-4455-B484-0B39A37541C0

P577

Q26752346-4C7DBEA9-FDB3-4189-89D2-3B29401AD76D

P5875

Q26752346-081D88E6-B886-4EA4-AD98-A3D5DA4261B4

P698

Q26752346-84393689-9D58-4BD8-B0F9-B19D8497CC10

P921

Q26752346-970E79FD-9FF3-4872-A908-19A1B55E0F2A

P932

Q26752346-BD35ADCE-D959-490E-8D75-911B79F0886B

P3181

P356

VACCINES4020010

P1433

P1476

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

@en

P2093

Gonzalo A Pradenas

http://www.w3.org/2001/XMLSchema#string

P2860

A decade of Burkholderia cenocepacia virulence determinant research

Two quorum sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex

Burkholderia cenocepacia type VI secretion system mediates escape of type II secreted proteins into the cytoplasm of infected macrophages

Protein profiling analyses of the outer membrane of Burkholderia cenocepacia reveal a niche-specific proteome.

Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response

The ferret as a model organism to study influenza A virus infection.

Cable pili and the associated 22 kDa adhesin contribute to Burkholderia cenocepacia persistence in vivo.

Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.

IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources.

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2280848

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/VACCINES4020010

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Alfredo G Torres

Brittany N Ross

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301332404

http://www.w3.org/2001/XMLSchema#string

P698

27092530

http://www.w3.org/2001/XMLSchema#string

P921

Burkholderia cepacia

P932

4931627

http://www.w3.org/2001/XMLSchema#string